moxie Aesthetic Intelligence — Partner Insights
● Wireframe · measured Omni data + labeled estimates

Aesthetic Network Insights

First-party intelligence across the independent & emerging medspa network · Trailing 12 months through June 2026

859
Medspas in network
286,414
Tox treatments (T12M)
$50.1M
Net tox revenue
63,427
Filler treatments
$19.8M
Net filler revenue
View Full network · T12M through June 2026
Region
Size
Tenure
Client age
FILTERS · ROADMAP

Xeomin vs. segment survey — tox brand share

Xeomin penetration — region × practice size

Omni · real · % of practices w/ Xeomin

Tox brand share over time

T12M, monthly

Patients requesting brand by name

survey signal

Supplier footprint vs. primacy — who practices order from, and who they call #1

survey · n≈77 · overall and $100K+/mo practices

Xeomin revenue & penetration — region × practice size (real)

Omni · Invoices & Transactions · T12M

Radiesse / Belotero — filler footprint (floor, not full mix)

Omni · grounded · T12M

The Merz-practice profile vs. comparison set

How to read this ▸
Associations, not causation — higher-performing practices may simply adopt premium brands sooner. All figures illustrative.

Patient retention — Merz-forward vs. comparison

% retained over 12 months

Next-product attach — Merz patient

within 180 days

Cross-sell attach — flat across tox brands

Omni · Q9+Q10 · T12M

Seasonality — % vs baseline

index, 100 = baseline · growth removed · Jan–Dec

Service mix of revenue

Moxie practice growth vs. the market — by region

Omni (Moxie) · industry benchmarks (market) · T12M

The Dysport precedent — what a brand-specific Meta campaign delivers

Meta-attributed revenue share — by tox brand

Omni · Lead Source Group × brand · T12M · real

Expected volume change — next 12 months

% of practices expecting an increase, no change, or decrease · directional

Average basket size

90-day re-order rate — same brand

Patient financing (BNPL) — bigger tickets, and Xeomin leads

Omni · Payments & Refunds × Invoices · T12M · real

Tox brand ordering mix

Omni · Q11 · Shopify · T12M

Patient pricing by practice size — paid lines

Omni · Q30 · T12M · $0 redemption lines excluded

Markup on tox — Xeomin vs. other brands

avg. patient markup by primary brand

Discount depth needed to trigger a brand switch

survey signal · 15%-off figure measured, adjacent rungs directional

What would actually make a practice shift brand volume

survey · n=74 · multi-select, up to 3

Why practices chose their primary supplier

survey · % ranking each factor #1, by primary supplier

How practices respond to supplier promotions

survey · n=74 · single-select